Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRMP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | SPATS1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | LCN8 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
mRNA | PRR19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | STOX1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | SHANK3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | GPR63 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | NQO1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | TDG | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | C1orf186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |